Related Experiment Video
Updated: Aug 22, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Enhanced T cell effector activity by targeting the Mediator kinase module
Katherine A Freitas1,2, Julia A Belk3, Elena Sotillo2
1Immunology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA.
Abstract:
T cells are the major arm of the immune system responsible for controlling and regressing cancers. To identify genes limiting T cell function, we conducted genome-wide CRISPR knockout screens in human chimeric antigen receptor (CAR) T cells. Top hits were MED12 and CCNC, components of the Mediator kinase module. Targeted MED12 deletion enhanced antitumor activity and sustained the effector phenotype in CAR- and T cell receptor-engineered T cells, and inhibition of CDK8/19 kinase activity increased expansion of nonengineered T cells. MED12-deficient T cells manifested increased core Meditator chromatin occupancy at transcriptionally active enhancers-most notably for STAT and AP-1 transcription factors-and increased IL2RA expression and interleukin-2 sensitivity. These results implicate Mediator in T cell effector programming and identify the kinase module as a target for enhancing potency of antitumor T cell responses.
Insights
Researchers identified MED12 and CCNC as key genes limiting T cell function in cancer immunotherapy. Deleting MED12 boosts antitumor activity, offering a new target for enhancing T cell responses.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- T cells are crucial for cancer regression.
- Identifying factors limiting T cell function is vital for improving immunotherapies.
Purpose of the Study:
- To identify genes that limit T cell function in engineered T cells.
- To explore the role of the Mediator kinase module in T cell effector programming.
Main Methods:
- Genome-wide CRISPR knockout screens were performed in human chimeric antigen receptor (CAR) T cells.
- MED12 and CCNC were identified as top hits limiting T cell function.
- Targeted MED12 deletion and CDK8/19 kinase inhibition were investigated.
Main Results:
- Targeted MED12 deletion enhanced antitumor activity and sustained effector phenotype in engineered T cells.
- Inhibition of CDK8/19 kinase activity increased non-engineered T cell expansion.
- MED12-deficient T cells showed increased Mediator chromatin occupancy and IL2RA expression.
Conclusions:
- The Mediator kinase module plays a significant role in T cell effector programming.
- Targeting MED12 and related kinases presents a promising strategy for enhancing antitumor T cell potency.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways

